Q32 Bio Income Statement (2017-2026) | QTTB

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
1.68M0.80M0.80M0.80M0.80M0.80M2.95M3.21M1.86M-1.36M
Operating items
Research & Development (Quarter)
23.99M23.65M24.27M21.07M25.85M27.15M7.91M8.02M7.46M8.34M9.84M13.41M14.35M10.54M7.12M5.16M3.56M3.31M3.22M4.26M
Selling, General & Administrative (Quarter)
8.35M10.78M14.15M8.03M7.81M8.15M2.41M2.46M2.19M2.81M5.00M4.51M4.47M3.98M5.10M4.01M4.02M4.54M4.50M4.86M
Restructuring Costs (Quarter)
6.64M2.69M
Other Operating Expenses (Quarter)
131.25M
Operating Expenses (Quarter)
32.34M34.43M38.42M29.11M33.66M35.30M10.32M10.48M9.66M11.15M14.84M17.92M18.81M14.53M12.23M9.17M7.58M7.86M7.72M9.12M
Operating Income (Quarter)
-30.66M-33.62M-37.62M-28.31M-32.86M-34.49M-7.37M-7.28M-7.80M-25.81M-14.84M-17.92M-18.81M-14.53M-12.23M-9.17M-7.58M45.88M-7.72M-9.12M
EBIT (Quarter)
-30.66M-33.62M-37.62M-28.31M-32.86M-34.49M-7.37M-7.28M-7.80M-25.81M-14.84M-17.92M-18.81M-14.53M-12.23M-9.17M-7.58M45.88M-7.72M-9.12M
Non-operating items
Non Operating Investment Income (Quarter)
-0.59M-1.36M-2.18M
Interest & Investment Income (Quarter)
0.05M0.04M0.03M0.47M1.27M1.46M1.47M1.51M1.42M1.18M
Other Non Operating Income (Quarter)
0.05M8.80M131.28M0.47M1.27M-119.07M0.58M0.17M0.08M0.20M0.16M2.39M1.22M0.36M1.20M-0.32M0.19M0.11M0.11M0.32M
Non Operating Income (Quarter)
0.54M1.47M-6.17M-1.00M16.05M2.39M1.22M0.36M1.20M-0.32M0.19M11.85M0.11M0.17M
Net income details
EBT (Quarter)
-30.61M-33.58M93.66M-27.83M-31.59M-33.04M-6.84M-5.81M-13.97M-26.81M1.21M-15.53M-17.59M-14.17M-11.03M-9.49M-7.39M57.73M-16.09M-30.73M
Tax Provisions (Quarter)
-20.11M0.97M0.10M0.05M1.52M0.32M0.02M
Profit After Tax (Quarter)
-30.61M-33.58M92.11M-29.09M-33.73M-34.30M-6.84M-5.81M-14.03M26.62M1.03M-16.98M-17.59M-14.19M-11.03M-9.49M-7.39M57.72M-7.61M-8.95M
Income from Continuing Operations (Quarter)
-30.61M-13.47M92.70M-27.94M-31.64M-34.55M-6.84M-5.81M-13.97M-27.13M1.21M-15.53M-17.59M-14.19M-11.03M-9.49M-7.39M57.73M-16.09M-30.73M
Consolidated Net Income (Quarter)
-30.61M-13.47M92.70M-27.94M-31.64M-34.55M-6.84M-5.81M-13.97M-27.13M1.21M-15.53M-17.59M-14.19M-11.03M-9.49M-7.39M57.73M-16.09M-30.73M
Income towards Parent Company (Quarter)
-30.61M-13.47M92.70M-27.94M-31.64M-34.55M-6.84M-5.81M-13.97M-27.13M1.21M-15.53M-17.59M-14.19M-11.03M-9.49M-7.39M57.73M-16.09M-30.73M
Net Income towards Common Stockholders (Quarter)
-30.61M-13.47M92.70M-27.94M-31.64M-34.55M-6.84M-5.81M-14.03M26.62M1.03M-16.98M-17.59M33.50M-11.03M-9.49M-7.39M27.94M-7.61M-8.95M
Additional items
EPS (Basic) (Quarter)
-9.65-4.3929.13-8.76-9.91-10.84-2.13-1.81-4.378.291.03-1.42-1.463.59-0.90-0.78-0.602.27-0.54-0.44
EPS (Diluted) (Quarter)
-9.65-4.3928.83-8.76-9.91-10.84-2.13-1.81-4.378.290.44-1.42-1.463.47-0.90-0.78-0.602.27-0.54-0.44
Shares Outstanding (Quarter)
3.17M3.07M3.18M3.19M3.19M3.19M3.21M3.21M3.21M3.21M1.00M11.96M12.08M9.32M12.20M12.20M12.24M12.30M14.10M20.34M
Shares Outstanding (Diluted) (Quarter)
3.17M3.07M3.22M3.19M3.19M3.19M3.21M3.21M3.21M3.21M2.33M11.96M12.08M9.66M12.20M12.20M12.24M12.31M14.10M20.34M
Shares Outstanding (Entity) (Quarter)
3.18M3.18M3.19M3.19M3.19M3.19M3.21M3.21M3.22M3.21M1.00M12.00M12.14M9.32M12.20M12.20M12.30M12.86M14.63M20.34M
EBITDA (Quarter)
-30.66M-33.62M-37.62M-28.31M-32.86M-34.49M-7.37M-7.28M-7.80M-25.81M-14.84M-17.92M-18.81M-14.53M-12.23M-9.17M-7.58M45.88M-7.72M-9.12M
Interest Expenses (Quarter)
17.34M163.39M47.45M46.71M45.96M179.65M0.40M0.25M0.49M4.00M10.62M12.00M62.83M0.40M1.12M7.59M1.12M0.20M8.37M21.61M
Tax Rate (Quarter)
59.88%1.03%-0.38%-0.15%-4.59%-1.19%-0.15%